Concepts (329)
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Tatyana Golovkina's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Tatyana Golovkina has written about over time.
Mammary Tumor Virus, MouseMammary Neoplasms, ExperimentalTumor Virus InfectionsMiceAnimalsAntibodies, ViralRetroviridae InfectionsImmunity, InnateMice, Inbred StrainsLeukemia Virus, MurineVirus DiseasesRetroviridaeVirusesAntibodies, NeutralizingImmunity, HumoralSymbiosisHistocompatibility Antigens Class IIHLA-D AntigensImmunoglobulinsReceptors, Antigen, T-Cell
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Mammary Tumor Virus, Mouse | 41 | 1985 | 2017 | February 2000 |
| Mammary Neoplasms, Experimental | 11 | 1993 | 2006 | April 2000 |
| Tumor Virus Infections | 17 | 1992 | 2011 | May 2001 |
| Mice | 57 | 1987 | 2024 | December 2005 |
| Animals | 61 | 1987 | 2024 | February 2006 |
| Antibodies, Viral | 11 | 1987 | 2018 | May 2006 |
| Retroviridae Infections | 23 | 1993 | 2023 | July 2006 |
| Immunity, Innate | 11 | 2000 | 2019 | June 2009 |
| Mice, Inbred Strains | 9 | 1995 | 2023 | July 2010 |
| Leukemia Virus, Murine | 5 | 2002 | 2023 | June 2011 |
| Virus Diseases | 5 | 2009 | 2019 | August 2013 |
| Retroviridae | 5 | 1991 | 2023 | December 2013 |
| Viruses | 5 | 2009 | 2019 | November 2014 |
| Antibodies, Neutralizing | 6 | 2011 | 2020 | August 2015 |
| Immunity, Humoral | 2 | 2014 | 2017 | November 2015 |
| Symbiosis | 4 | 2013 | 2022 | July 2016 |
| Histocompatibility Antigens Class II | 6 | 2001 | 2024 | November 2017 |
| HLA-D Antigens | 3 | 2017 | 2021 | January 2020 |
| Immunoglobulins | 2 | 2021 | 2024 | October 2022 |
| Receptors, Antigen, T-Cell | 2 | 2021 | 2024 | January 2023 |
To return to the timeline,
click here.